Form4insider filings, from the source

SEC Form 4 · accession 0001354488-15-003965

PERNIX THERAPEUTICS HOLDINGS, INC. · PTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Terence Novak
Officer — Chief Operating Officer
Period of report
Aug 14, 2015
Accepted (ET)
Aug 18, 2015 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Options (right to buy)F1$4.70Aug 14, 2015A0A—Aug 14, 2025Common Stock—0D
Options (right to buy)F2$4.70Aug 14, 2015A120,000A—Aug 14, 2025Common Stock120,000120,000D

Explanation of responses